0

baddrivers

Justices: Generic drug design-defect claims preempted 

  • by
    • June 24, 2013

WASHINGTON — In a victory to generic pharmaceutical companies, the U.S. Supreme Court ruled today that state design-defect laws that impose a duty on generic drug makers to either change their labeling in violation of federal law or pull the drug from the market are preempted.
“[S]tate laws that require » […]

Original post by http://lawyersusaonline.com/blog/2013/06/24/justices-generic-drug-design-defect-claims-preempted/

Report bad drivers!

Related posts:

  1. Justices to rule on preemption of drug design defect claims  The U.S. Supreme Court has agreed to decide whether federal law preempts state law design defect claims targeting generic pharmaceutical...
  2. Generic Reglan claim isn’t preempted  Federal law does not preempt a product liability suit against drug maker PLIVA based on the company’s alleged failure to...
  3. Stryker not strictly liable for design defect  Medical device makers could not be held strictly liable for an alleged design defect in a surgically implanted prosthetic device,...
  4. Generic drug user can sue brand-name manufacturer  State law allows the user of a generic drug to sue the maker of the name-brand drug for fraudulent misrepresentation,...
  5. Generic drug maker faces liability for out-of-date warning label  Federal law does not preempt a product liability suit alleging that the maker of a generic form of Fosamax failed...

Leave a comment